Abstract PS2-02-06: Benefit of adjuvant chemotherapy for early-stage hormone receptor positive and HER2 negative lobular breast cancer patients: Analysis based on genomic risk scores
Authors
Stephen Myers (ORCID: https://orcid.org/0000-0003-4793-3820)
Margaret E. Gatti‐Mays (ORCID: https://orcid.org/0000-0001-8914-2897)
Abstract PS2-02-06: Benefit of adjuvant chemotherapy for early-stage hormone receptor positive and HER2 negative lobular breast cancer patients: Analysis based on genomic risk scores
Stephen Myers, Margaret E. Gatti‐Mays, Dionisia Quiroga, Gilbert Bader et al.
Journal
Clinical Cancer Research
Topics
Breast Cancer Treatment Studies
article
Abstract PS2-02-06: Benefit of adjuvant chemotherapy for early-stage hormone receptor positive and HER2 negative lobular breast cancer patients: Analysis based on genomic risk scores
Stephen Myers, Margaret E. Gatti‐Mays, Dionisia Quiroga, Gilbert Bader, Ashley Pariser Davenport, Emily Burke, Brandon Slover, A. M. Roy, S. D. Sardesai, M. A. Cherian, N. Williams, Y. Gokun, R. Wesolowski, N. Lopetegui-Lia, K. Johnson, D. G. Stover